These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 6903495)

  • 21. [Bactericidal dosie-activity relationships with E. coli, K. pneumoniae and Staph. aureus (author's transl)].
    Shah PM; Junghanns ; Stille W
    Dtsch Med Wochenschr; 1976 Feb; 101(9):325-8. PubMed ID: 174881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Staphylococci resistant to semisynthetic penicillins, isolated from patients].
    Shneerson AN; Rezvan SP
    Antibiotiki; 1967 Jan; 12(1):60-6. PubMed ID: 4298633
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Graninger W; Leitha T; Havel M; Georgopoulos A
    Infection; 1984; 12(4):293-5. PubMed ID: 6092279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro action of fosfomycin combined with rifampicin, pefloxacin and imipenem on staphylococci (checkerboard method in a liquid medium)].
    Quentin C; Noury P; Laurent C; Saivin S; Bebear C
    Pathol Biol (Paris); 1987 Feb; 35(2):153-7. PubMed ID: 3550623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sensitivity of Staphylococcus aureus towards commonly used chemotherapeutic agents. Microdetermination of the minimum inhibiting concentration].
    Wiedemann B; Knoche H
    Arzneimittelforschung; 1973 Mar; 23(3):477-9. PubMed ID: 4488466
    [No Abstract]   [Full Text] [Related]  

  • 26. [Some regularities in the development of resistance to oxacillin and benzylpenicillin in Staphylococci on the model of chick embryo].
    Voropaeva SD; Mogilevskaia NI; Polkovnikova TF
    Antibiotiki; 1966 Jun; 11(6):557-61. PubMed ID: 5185626
    [No Abstract]   [Full Text] [Related]  

  • 27. [Multiple resistance of staphylococci, isolated from the patients].
    Voropaeva SD
    Antibiotiki; 1969 May; 14(5):415-9. PubMed ID: 5192737
    [No Abstract]   [Full Text] [Related]  

  • 28. [Sensitivity of Staphylococci and enterococci to staphylomycin with special consideration of urine-bacteria].
    Knoll KH
    Arzneimittelforschung; 1969 Jun; 19(6):1021-4. PubMed ID: 4979617
    [No Abstract]   [Full Text] [Related]  

  • 29. Combined action of fosfomycin with beta-lactam and aminoglycoside antibiotics.
    Borowski J; Linda H
    Chemotherapy; 1977; 23 Suppl 1():82-5. PubMed ID: 318979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Methicillin-resistant staphylococci: biological properties and sensitivity to antibiotics].
    Speranskaia ON; Fomina IP; Kuznetsova SM
    Antibiotiki; 1973 Jan; 18(1):62-8. PubMed ID: 4486587
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of different combinations of sparfloxacin, oxacillin, and fosfomycin against methicillin-resistant staphylococci.
    Ferrara A; Dos Santos C; Cimbro M; Gialdroni Grassi G
    Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):535-7. PubMed ID: 9272391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Staphylococci isolated from clinical sources. 2. Comparison of antibiotic sensitivities of coagulase-positive and coagulase-negative staphylococci].
    Osada F; Ikeda Y; Watanabe S; Oashi S; Kobayashi S
    Rinsho Byori; 1972 Sep; 20(9):667-72. PubMed ID: 4486055
    [No Abstract]   [Full Text] [Related]  

  • 33. [Current status of the resistance behavior of staphylococci to isoxazolyl penicillins (oxa-, cloxa-, and dicloxacillin)].
    Matz K; Schassan HH; Faerber CH; Kornmüller KJ
    Zentralbl Bakteriol Orig A; 1974; 228(1):270-2. PubMed ID: 4154678
    [No Abstract]   [Full Text] [Related]  

  • 34. [Expression of staphylococci resistance to oxacillin and cefalotin ].
    Reynaud A; Drugeon HB; Chung SS; Courtieu AL
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):489-94. PubMed ID: 6750519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United States.
    Biedenbach DJ; Ross JE; Fritsche TR; Sader HS; Jones RN
    J Clin Microbiol; 2007 Mar; 45(3):998-1004. PubMed ID: 17215346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rifamycins, vancomycin and fosfomycin. A privileged use: Staphylococci resistant to methicillin].
    Régnier B
    Rev Prat; 1988 May; 38(16):1021-9. PubMed ID: 3406643
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative experimental study of ceporin and oxacillin].
    Zhukov VG; Navashin SM
    Antibiotiki; 1970 Feb; 15(2):120-3. PubMed ID: 4910122
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical strains of staphylococci resistant to semisynthetic penicillins].
    Shneerson AN
    Antibiotiki; 1967 Oct; 12(10):950-8. PubMed ID: 4871268
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on the effect of semisynthetic penicillins on Staphylococcus aureus].
    Ganczarski A; Pszczólska G; Kowalska D
    Pol Tyg Lek; 1969 Jan; 24(4):136-9. PubMed ID: 5191723
    [No Abstract]   [Full Text] [Related]  

  • 40. [Increase of hemolysin production of staphylococci under the influence of penicillin].
    Ritzerfeld W; Winterhoff D; Kienitz M
    Zentralbl Bakteriol Orig; 1966 Apr; 199(4):478-83. PubMed ID: 5183097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.